Exhibitor Information - Virtual


The deadline to submit a Notice of Intent to Support/Exhibit Application is October 1, 2020

Virtual Packages

 
 Small $3,750   Medium $7,500  Large $45,000  Extra Large $75,000
 Company Name on Virtual 
 Exhibits Page and Profile
 Virtual Exhibits Page 
 Button  
 Virtual Exhibits Page Button
 with Logo
 Virtual Exhibits Page Button
 with Logo
 Company Name  Company Name  Company Name  Company Name
 Website URL  Website URL  Website URL  Website URL
 Location  Location  Location
 Location
 Up to 3 Product and Service Categories  Up to 5 Product and Service
 Categories
 Up to 7 Product and Service
 Categories
 Up to 9 Product and Service
 Categories
  
 Company Logo   Company Logo
  250 Character Description  600 Character Description  800 Character Count Description  800 Character Count Description
   One Image Three Images  Five Images
   Opportunity to Network with
 Registered Attendees*
 Opportunity to Network with
 Registered Attendees*
 Opportunity to Network with
 Registered Attendees*
     Social Media Platform Links  Social Media Platform Links
     Company Banner  Company Banner
     One Flash Video up to 5   minutes  3 Flash Videos up to 5 minutes   each
     Five PDFs  20 PDFs
   2 Full Virtual Meeting Registrations  6 Full Virtual Meeting
 Registrations 
 10 Full Virtual Meeting
 Registrations

Individual Registration is required.

  • You will receive a confirmation email with further information after application and payment are received. 
  • Information may be updated any time prior to November 30, 2020. 
  • All content is subject to SABCS approval. 
  • SABCS reserves the right to make changes to content, as needed. 
  • It is the responsibility of the exhibiting company contact to ensure the company's information is submitted accurately.

Publishers

Publishers receive a 30% discount on all virtual packages. Publishers taking advantage of this rate are required to offer publications in print, on CD, DVD or other "hard" media for sale or order at their booth.


Non-Profit Organizations

Non-profit organizations receive a 30% discount all virtual packages. Documentation of 501(c)(3) status must accompany the exhibit application.


Exhibitor Eligibility Requirements

Exhibit applications are subject to approval by SABCS management. SABCS reserves the right to accept or reject a potential exhibitor based on our assessment of whether that company or organization's products and/or services are relevant to Symposium attendees. Exhibits promoting meetings which compete with SABCS in regards to content or schedule will not be approved.

SABCS may also accept or reject a potential exhibitor based on past compliance with SABCS exhibit rules.

Exhibits will be limited only to the company and the product(s) listed on the application. Only the sign of the company whose name appears on the application may be placed in the booth or appear on any printed list of exhibitors.

All exhibited items must comply with local, state, and FDA regulations.

All exhibits will be reviewed.


Complimentary Registrations

Program and exhibit area registration is required in order to attend SABCS programs.

How to Register:

SABCS will set up a registration management page for each exhibitor. Upon receipt of exhibit fee payment, a link, login, password and information regarding the number of complimentary registrations earned will be e-mailed to the exhibitor’s registration contact which the exhibitor has provided on the support/exhibit application.

If registrations over and above the number of complimentary registrations are needed, they can be purchased through the exhibitor’s registration management page. Additional exhibit area only, program and exhibit area registrations can be purchased at the published rates and discount.

Should the exhibitor registration contact have questions or issues, please contact SABCS at sabcs@uthscsa.edu or 210-450-1550.


Exhibit Placement

Upon approval and payment, exhibit space will be assigned to each company which has submitted a completed Notice of Intent to Support/Exhibit Application and exhibit fee payment.

Preliminary exhibit placement and notification for each exhibit will be made in October, if payment has cleared. Final exhibit placement and notifications will be sent in November. Apply early for the best chance to receive your preferred placement!

Exhibit placement is primarily determined using a formula based upon 

  • corporate sponsorship + exhibit fee
  • previous history with SABCS.

Also considered are such factors as preferred placement away from or near another exhibitor and size of exhibit. Preferred location can be indicated on the Notice of Intent to Support/Exhibit Application. Please note that although we will make every effort to accommodate your preference, placement according to preference is not guaranteed.


Code of Conduct

Exhibitors agree to adhere to the compliance guidelines and codes of conduct governing the interactions of drug and device manufacturers with healthcare professionals as promulgated by the U.S. Food and Drug Administration, the Department of Health and Human Services Office of the Inspector General, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Advanced Medical Technology Association (AdvaMed).


Exhibit Rules

  • Sharing of booth space with an unrelated company is not permitted.
  • “Subleasing” of booth space with an unrelated company is not permitted.

Preliminary Exhibit Schedule

Hours may be subject to change.

Exhibits Open
Wednesday, December 9
10:00 AM – 5:00 PM
Thursday, December 10
10:00 AM – 5:00 PM
Friday, December 11
10:00 AM – 5:00 PM
Exhibitor Registration Hours
Monday, December 7
8:00 AM - 5:00 PM
Tuesday, December 8
8:00 AM - 7:00 PM
Wednesday, December 9
7:00 AM - 5:15 PM
Thursday, December 10
6:45 AM - 5:15 PM
Friday, December 11
6:45 AM - 4:00 PM

Cancellation Policy

  • Refund less 75% if cancelled by October 15, 2020.
  • This policy also applies to reduction of exhibit.
  • Positively no refund for cancellations thereafter.

2020 SABCS Exhibitors

                                                                                                                                                                                                                                                                                                            
Agendia
Agilent/Dako
Alamo Breast Cancer Foundation
AstraZeneca  
Athenex Oncology                                                                                                                                                      
Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine  
BeyondSpring Pharmaceuticals
Biotheranostics, Inc  
Breast Cancer Action  
Bristol Myers Squibb
Caris Life Sciences  
Coherus BioSciences, Inc  
Daiichi Sankyo  
Eisai, Inc.  
Elsevier  
Encore Medical Education, LLC
Exact Sciences (formerly Genomic Health) 
Foundation Medicine, Inc  
Fresenius Kabi 
Guardant Health
Immunomedics    
Invitae  
Lilly Oncology  
Male Breast Cancer Coalition  
METAvivor  Research and Support, Inc   
Natera  
NeoGenomics Laboratories  
Novartis Oncology  
The Oncologist  
Pfizer
Puma Biotechnology, Inc    
Seattle Genetics   
UT MD Anderson Cancer Center

 






In collaboration with  Astro     and     SSO